Patents by Inventor Philippe Moreillon

Philippe Moreillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIAL LYSINS AND USES THEREOF
    Publication number: 20160145591
    Abstract: The present invention relates to substances and compositions thereof useful in the prevention and/or treatment of bacterial infections and disorders, in particular bacteremia caused by group B Streptococcus. In another aspect, the invention relates to substances and compositions thereof useful for decontaminating biological or inanimate materials which could be contaminated by Gram-positive bacteria. In a further aspect, the invention relates to substances and compositions thereof useful for detecting the presence of certain Gram-positive bacteria in biological or inanimate materials.
    Type: Application
    Filed: July 15, 2014
    Publication date: May 26, 2016
    Inventors: Grégory RESCH, Frank OECHSLIN, Philippe MOREILLON
  • IMMUNOGENIC COMPOSITION COMPRISING AN INACTIVATED RECOMBINANT NON-PATHOGENIC BACTERIUM
    Publication number: 20150265692
    Abstract: The present invention relates to immunogenic compositions, vaccines and antibodies for the treatment and/or prevention of infections and diseases caused by S. aureus in a subject in need thereof.
    Type: Application
    Filed: September 4, 2013
    Publication date: September 24, 2015
    Inventors: Jose Entenza, Philippe Moreillon, Tiago Rafael Veloso, Yok-ai Que, Mathilde Ythier
  • Dalfopristine/quinupristine combinations with cefpirome
    Patent number: 7005416
    Abstract: A pharmaceutical composition comprising synergistically effective amounts of cefpirome and dalfopristine/quinupristine combination. A method of treating a patient comprising the administration of synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination. Kits comprising synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination are also disclosed.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: February 28, 2006
    Assignee: Jones Pharma Incorporated
    Inventors: Céline Feger, Philippe Moreillon, Jacques Vouillamoz
  • New molecular tools for the rapid assessment of the presence and viability of microorganisms and methods of use
    Publication number: 20040110247
    Abstract: Overall ratios of ribosomal DNA and ribosomal RNA in microorganisms following exposure to an antimicrobial is shown to correspond to the presence and viability of the microorganism. Methods are provided to assess the presence and viability of microorganisms, by administering an antimicrobial to a population of microorganisms having a first and second marker, quantifying the first and second markers, and determining the ratio between the quantity of the first and second marker. A concordant result indicates the presence of viable microorganisms, whereas a discordant result indicates the presence of non-viable microorganisms.
    Type: Application
    Filed: August 8, 2003
    Publication date: June 10, 2004
    Inventors: Philippe Moreillon, Yok Ai Que, Steve Aellen
  • Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime
    Patent number: 6465428
    Abstract: The present invention relates to pharmaceutical combinations of group A and group B streptogramins, in particular to combinations of dalfopristine and quinupristine, with cefepime, which combinations can exhibit a synergism of antibiotic action, to pharmaceutical compositions comprising the active ingredients, and to the bactericidal and bacteriostatic use of the combinations and compositions.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: October 15, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Celine Feger, Harriette Nadler, Philippe Moreillon
  • Dalfopristine/quinupristine combinations with cefpirome
    Publication number: 20020037890
    Abstract: A pharmaceutical composition comprising synergistically effective amounts of cefpirome and dalfopristine/quinupristine combination. A method of treating a patient comprising the administration of synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination. Kits comprising synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination are also disclosed.
    Type: Application
    Filed: August 3, 2001
    Publication date: March 28, 2002
    Inventors: Celine Feger, Philippe Moreillon, Jacques Vouillamoz